A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy
Clinical trial NCT05568459 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05568459
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-17
- Primary completion
- 2026-08-21
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.